# SODIUM NITROPRUSSIDE
> **ANDA214971** · Abbreviated New Drug Application (Generic) · Sponsor: BE PHARMS · Approved 2021-07-12
## Drug
- **FDA Application Number:** ANDA214971
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SODIUM NITROPRUSSIDE
- **Generic name:** SODIUM NITROPRUSSIDE
- **Active ingredients:** SODIUM NITROPRUSSIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** BE PHARMS
- **Manufacturer:** BE Pharmaceuticals Inc.
- **First approval:** 2021-07-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214971)
---
*MORVS · CC0 1.0*